Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Indraprastha Medical's OCF Yield % or its related term are showing as below:
BOM:532150'
s OCF Yield % Range Over the Past 10 Years
Min: 4.79 Med: 0 Max: 4.79
Current: 4.79
During the past 13 years, the highest OCF Yield % of Indraprastha Medical was 4.79%. The lowest was 4.79%. And the median was %.
BOM:532150's OCF Yield % is ranked worse than 52.06% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 5.225
vs BOM:532150: 4.79
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Indraprastha Medical OCF Yield % Related Terms
Indraprastha Medical OCF Yield % Historical Data
* Premium members only.
The historical data trend for Indraprastha Medical's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:532150 vs HCA, THC, DVA: OCF Yield % Comparison
For the Medical Care Facilities subindustry, Indraprastha Medical's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indraprastha Medical OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Indraprastha Medical's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Indraprastha Medical's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indraprastha Medical (BOM:532150) has a OCF Yield % of 4.79 as of Aug. 13, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Indraprastha Medical and its competitors. Over the past decade, Indraprastha Medical's OCF Yield % has ranged from 4.79 to 4.79. According to the industry distribution chart, Indraprastha Medical ranks #354 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 52.1%.
Is Indraprastha Medical's OCF Yield % too high?
Indraprastha Medical's current OCF Yield % is 4.79. Over the past 10 years, this metric has ranged from a low of 4.79 to a high of 4.79. The Healthcare Providers & Services industry median OCF Yield % is 5.23. Indraprastha Medical's value of 4.79 is 8.3% below this industry median. Based on the distribution chart, Indraprastha Medical ranks #354 out of 680 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Indraprastha Medical has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Indraprastha Medical's OCF Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Indraprastha Medical ranks #354 out of 680 companies for OCF Yield %. This places Indraprastha Medical in the lower half of its industry. The industry median OCF Yield % is 5.23. Indraprastha Medical's value of 4.79 is 8.3% below this benchmark. Historically, Indraprastha Medical's own OCF Yield % has ranged from 4.79 to 4.79 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.23, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indraprastha Medical's current OCF Yield % of 4.79 is 8.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Indraprastha Medical and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indraprastha Medical's current OCF Yield % is 4.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indraprastha Medical stock overvalued right now?
Based on GuruFocus' analysis, Indraprastha Medical (BOM:532150) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹420.21, compared to a current price of ₹376.95 — trading 10.3% below its estimated fair value. The current OCF Yield % is 4.79 and 8.3% below the Healthcare Providers & Services industry median of 5.23. Indraprastha Medical's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Indraprastha Medical (BOM:532150), the current OCF Yield % is 4.79 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indraprastha Medical (BOM:532150) Overvalued in 2026?
Based on GuruFocus' analysis, Indraprastha Medical stock appears to be undervalued.
The current stock price of ₹376.95 is trading 10.3% below its estimated GF Value™ of ₹420.21.
GuruFocus considers Indraprastha Medical to be Modestly Undervalued.
Key valuation signals for BOM:532150:
OCF Yield %: 4.79
GF Value™: ₹420.21 vs. price of ₹376.95 (10.3% below fair value)
Industry Position: 8.3% below the Healthcare Providers & Services median (#354 of 680)
No single metric tells the full story. See the BOM:532150 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indraprastha Medical Corp Ltd is an Indian company that operates in the healthcare business. It offers services in the field of anaesthesiology, pediatrics, bone marrow transplant, dental surgery, neonatology, dermatology, obesity, and metabolic surgery, orthopaedics, robotic surgery, spine surgery and in many other areas. The company also provides diagnosis, treatment, and management of various hormonal disorders; and inpatient and ambulatory care services. Geographically all the business activities of the group are carried out through the regions of India. It derives revenue from the provision of services.
81GF Score
Get the complete analysis for BOM:532150
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532150 has been successfully added to your 
